 | Up a level |
Hinsley, Samantha and Walker, Katrina and Sherratt, Debbie and Bailey, Lucy and Reed, Sadie and Flanagan, Louise and McKee, Sophie and Brudenell Straw, Fiona and Dawkins, Bryony and Meads, David and Auner, Holger W and Kaiser, Martin F and Cook, Mark and Brown, Sarah and Cook, Gordon (2020) The MUK eight protocol: a randomised phase II trial of cyclophosphamide and dexamethasone in combination with ixazomib, in relapsed or refractory multiple myeloma (RRMM) patients who have relapsed after treatment with thalidomide, lenalidomide and a proteasome inhibitor. Trials, 21 (1). p. 826. ISSN 1745-6215.
